Aponia Laboratories, Inc.
2 clinical trials · Sponsor
◉ Watch Aponia Laboratories, Inc.
| Record | Firm | Date |
|---|---|---|
| Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS (NCT03852459) | Aponia Laboratories, Inc. | 2018-01-12 |
Track Aponia Laboratories, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.